Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Medical Devices

Problem with Quality of Mammograms at Boston Diagnostic Imaging in Orlando, Florida: FDA Safety Communication

FDA has issued a status update on this facility.

Date Issued: August 17, 2015


  • Patients who had mammograms at Boston Diagnostic Imaging located in Orlando, Florida, any time on or after May 13, 2013.
  • Health care providers who have referred patients to Boston Diagnostic Imaging located in Orlando, Florida, for a mammogram performed any time on or after May 13, 2013.

Medical Specialty: Primary Care, Family Medicine, Internal Medicine, Obstetrics and Gynecology, Radiation Oncology, Radiology, General Surgery, Breast Surgery

A mammogram is a safe, low-dose X-ray picture of the breast. It is currently the most effective method of detecting breast cancer in its earliest, most treatable stages.

The FDA is alerting patients who had mammograms at Boston Diagnostic Imaging located in Orlando, Florida, anytime on or after May 13, 2013, about possible problems with the quality of their mammograms. This does not mean that the results of the mammograms were inaccurate, but it does mean that the patients should consider having their mammograms re-evaluated at a Mammography Quality Standards Act (MQSA)-certified facility to determine if the patients need a repeat mammogram or additional medical follow-up. Patients have the right to request their mammogram and copies of their medical reports from Boston Diagnostic Imaging.

Summary of Problem or Scope:
The FDA became aware of problems associated with the quality of mammograms performed at Boston Diagnostic Imaging located at the following address:

1751 S. Orange Avenue
Orlando, FL 32806

The American College of Radiology (ACR) conducted a clinical image review of mammograms performed by Boston Diagnostic Imaging between May 13, 2013, and May 13, 2015. The review was conducted after deficiencies were noted in the clinical cases that were submitted with the facility’s accreditation renewal application. The ACR revoked the facility’s application for mammography accreditation effective July 29, 2015. The FDA suspended the facility’s MQSA certificate on August 13, 2015, and directed the facility to cease performing mammography.

On August 13, 2015, the FDA directed the facility to notify all patients who received mammograms at Boston Diagnostic Imaging any time on or after May 13, 2013, and their referring health care providers, about the problems with the mammography quality at the facility.

Under the MQSA of 1992, the FDA requires that all mammography facilities meet certain baseline quality standards and be certified to legally operate in the United States. This facility did not meet standards for mammography quality under the Act. The facility may no longer legally perform mammography at this time due to the suspension of its MQSA certificate.

The FDA recommends the following for patients who had a mammogram at Boston Diagnostic Imaging any time on or after May 13, 2013:

  • If you have had a more recent mammogram at a MQSA-certified facility since then, you should follow the recommendations from that facility.
  • If you have not had a mammogram at an MQSA-certified facility since then, follow these guidelines:
    • Talk with your health care provider as soon as possible about your medical follow-up. You may need your mammogram re-evaluated, and possibly need a repeat mammogram and/or possible further evaluation.
    • If your health care provider recommends a repeat mammogram, it should be done at an MQSA-certified facility to ensure quality and accuracy. A database of MQSA-certified facilities in your area is available online or by calling the National Cancer Institute’s (NCI) information number at 1-800-422-6237.
    • If you need a repeat mammogram and your health insurance will not pay for it, you can call the National Cancer Institute’s (NCI) information number at 1-800-422-6237. Experts at this number may be able to identify a facility near you that provides free or low-cost mammograms.

FDA Activities:
The FDA will continue to monitor this issue and keep the public informed as new information becomes available. This safety communication is provided by the FDA’s commitment to inform the public about safety issues.

Contact Information:
If you have questions about this communication, please contact the MQSA Hotline at 1-800-838-7715, email your question to or fax to 1-410-290-6351.

Page Last Updated: 02/26/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English